- Home
- HAS vs MRNA Comparison
HAS vs MRNA Comparison
Compare HAS & MRNA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HAS
- MRNA
- Stock Information
- Founded
- HAS 1923
- MRNA 2010
- Country
- HAS United States
- MRNA United States
- Employees
- HAS N/A
- MRNA N/A
- Industry
- HAS Recreational Games/Products/Toys
- MRNA Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- HAS Consumer Discretionary
- MRNA Health Care
- Exchange
- HAS Nasdaq
- MRNA Nasdaq
- Market Cap
- HAS 11.5B
- MRNA 9.8B
- IPO Year
- HAS N/A
- MRNA 2018
- Fundamental
- Price
- HAS $73.14
- MRNA $26.25
- Analyst Decision
- HAS Strong Buy
- MRNA Hold
- Analyst Count
- HAS 10
- MRNA 17
- Target Price
- HAS $86.70
- MRNA $42.40
- AVG Volume (30 Days)
- HAS 1.6M
- MRNA 10.4M
- Earning Date
- HAS 10-23-2025
- MRNA 11-06-2025
- Dividend Yield
- HAS 3.83%
- MRNA N/A
- EPS Growth
- HAS N/A
- MRNA N/A
- EPS
- HAS N/A
- MRNA N/A
- Revenue
- HAS $4,250,800,000.00
- MRNA $3,078,000,000.00
- Revenue This Year
- HAS $7.65
- MRNA N/A
- Revenue Next Year
- HAS $4.72
- MRNA $10.45
- P/E Ratio
- HAS N/A
- MRNA N/A
- Revenue Growth
- HAS N/A
- MRNA N/A
- 52 Week Low
- HAS $49.00
- MRNA $23.15
- 52 Week High
- HAS $82.19
- MRNA $58.96
- Technical
- Relative Strength Index (RSI)
- HAS 41.13
- MRNA 48.69
- Support Level
- HAS $70.94
- MRNA $26.24
- Resistance Level
- HAS $76.07
- MRNA $28.06
- Average True Range (ATR)
- HAS 1.79
- MRNA 1.29
- MACD
- HAS -0.24
- MRNA 0.02
- Stochastic Oscillator
- HAS 35.37
- MRNA 42.24
About HAS Hasbro Inc.
Hasbro is a branded play company providing children and families around the world with entertainment offerings based on a world-class brand portfolio. From toys and games to television programming, motion pictures, and a licensing program, Hasbro reaches customers by leveraging its well-known brands such as Transformers, Nerf, and Magic: The Gathering. The firm acquired EOne in 2019, bolting on popular family properties like Peppa Pig and PJ Masks, and since has divested noncore lines from the tie-up. Furthermore, the addition of Dungeons & Dragons Beyond in 2022, offers the firm access to 19 million digital tabletop players.
About MRNA Moderna Inc.
Moderna is a commercial-stage biotech that was founded in 2010 and had its initial public offering in December 2018. The firm's mRNA technology was rapidly validated with its covid vaccine, which was authorized in the United States in December 2020. Moderna had 35 mRNA development candidates in clinical studies as of August 2025. Programs span a wide range of therapeutic areas, including infectious disease, oncology, cardiovascular disease, and rare genetic diseases.